Product Information

LEVSIN 0.125 MG TABLET is a brand product labeled by Viatris Specialty LLC, priced at $2.6566 per EA under NDC 68220011210. Its NADAC has been published 36 times since Dec 17, 2025.

The High Outlier badge above means this manufacturer's average price in the hyoscyamine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LEVSIN 0.125 MG TABLET

hyoscyamine sulfate
$2.6566per EA
High Outlier

Strength

.125 mg/1

NDC

68220011210

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

HYOSCYAMINE SULFATE

Approval Type

Unapproved

On Market Since

6/1/1955

Price Statistics

The NADAC for LEVSIN 0.125 MG TABLET has been published 36 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$2.6566 per EA
All-time high$2.6566 (Aug 19, 2026)
All-time low$2.6521 (Dec 17, 2025)
52-week high$2.6566
52-week low$2.6521
Median price$2.6526
Average price$2.6529
Largest weekly change+0.1% (Aug 19, 2026)
Weeks tracked36
Tracking sinceDec 17, 2025

Price History

1W

+0.1%

1M

+0.1%

3M

+0.1%

6M

+0.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LEVSIN 0.125 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVSIN 0.125 MG TABLET, manufactured by Viatris Specialty LLC, is $2.6566 per EA (NDC 68220011210), effective Aug 19, 2026.

How has the price of LEVSIN 0.125 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVSIN 0.125 MG TABLET has held within roughly two percent of its current level. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for LEVSIN 0.125 MG TABLET?

Since Dec 17, 2025, the NADAC for LEVSIN 0.125 MG TABLET has ranged from a low of $2.6521 (Dec 17, 2025) to a high of $2.6566 (Aug 19, 2026), with a median of $2.6526 per EA.

Are there cheaper alternatives to LEVSIN 0.125 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYOSCYAMINE SULF 0.125 MG TAB, is $0.1515 per EA — about 94% below LEVSIN 0.125 MG TABLET.

Who manufactures LEVSIN 0.125 MG TABLET?

LEVSIN 0.125 MG TABLET (NDC 68220011210) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.